Post-translational modifications of vertebrate striated muscle myosin heavy chains.
acetylation
cardiac muscle
myosin heavy chain
phosphorylation
post‐translational modifications
skeletal muscle
Journal
Cytoskeleton (Hoboken, N.J.)
ISSN: 1949-3592
Titre abrégé: Cytoskeleton (Hoboken)
Pays: United States
ID NLM: 101523844
Informations de publication
Date de publication:
08 Apr 2024
08 Apr 2024
Historique:
revised:
06
03
2024
received:
11
12
2023
accepted:
25
03
2024
medline:
8
4
2024
pubmed:
8
4
2024
entrez:
8
4
2024
Statut:
aheadofprint
Résumé
Post-translational modifications (PTMs) play a crucial role in regulating the function of many sarcomeric proteins, including myosin. Myosins comprise a family of motor proteins that play fundamental roles in cell motility in general and muscle contraction in particular. A myosin molecule consists of two myosin heavy chains (MyHCs) and two pairs of myosin light chains (MLCs); two MLCs are associated with the neck region of each MyHC's N-terminal head domain, while the two MyHC C-terminal tails form a coiled-coil that polymerizes with other MyHCs to form the thick filament backbone. Myosin undergoes extensive PTMs, and dysregulation of these PTMs may lead to abnormal muscle function and contribute to the development of myopathies and cardiovascular disorders. Recent studies have uncovered the significance of PTMs in regulating MyHC function and showed how these PTMs may provide additional modulation of contractile processes. Here, we discuss MyHC PTMs that have been biochemically and/or functionally studied in mammals' and rodents' striated muscle. We have identified hotspots or specific regions in three isoforms of myosin (MYH2, MYH6, and MYH7) where the prevalence of PTMs is more frequent and could potentially play a significant role in fine-tuning the activity of these proteins.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : HL160966
Pays : United States
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Abraham, W. T., Gilbert, E. M., Lowes, B. D., Minobe, W. A., Larrabee, P., Roden, R. L., Dutcher, D., Sederberg, J., Lindenfeld, J. A., Wolfel, E. E., Shakar, S. F., Ferguson, D., Volkman, K., Linseman, J. V., Quaife, R. A., Robertson, A. D., & Bristow, M. R. (2002). Coordinate changes in myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Molecular Medicine, 8(11), 750–760.
Aebersold, R., & Mann, M. (2003). Mass spectrometry‐based proteomics. Nature, 422(6928), 198–207.
Aslebagh, R., Wormwood, K. L., Channaveerappa, D., Wetie, A. G. N., Woods, A. G., & Darie, C. C. (2019). Identification of posttranslational modifications (PTMs) of proteins by mass spectrometry. In A. G. Woods & C. C. Darie (Eds.), Advancements of mass spectrometry in biomedical research (pp. 199–224). Springer International Publishing.
Audagnotto, M., & Dal Peraro, M. (2017). Protein post‐translational modifications: In silico prediction tools and molecular modeling. Computational and Structural Biotechnology Journal, 15, 307–319.
Bagwan, N., El Ali, H. H., & Lundby, A. (2021). Proteome‐wide profiling and mapping of post translational modifications in human hearts. Scientific Reports, 11(1), 2184.
Bárány, M. (1967). ATPase activity of myosin correlated with speed of muscle shortening. The Journal of General Physiology, 50(6), 197–218.
Barrick, S. K., & Greenberg, M. J. (2021). Cardiac myosin contraction and mechanotransduction in health and disease. The Journal of Biological Chemistry, 297(5), 101297.
Biesiadecki, B. J., & Westfall, M. V. (2019). Troponin I modulation of cardiac performance: Plasticity in the survival switch. Archives of Biochemistry and Biophysics, 664, 9–14.
Blankenfeldt, W., Thomä, N. H., Wray, J. S., Gautel, M., & Schlichting, I. (2006). Crystal structures of human cardiac beta‐myosin II S2‐delta provide insight into the functional role of the S2 subfragment. Proceedings of the National Academy of Sciences of the United States of America, 103(47), 17713–17717.
Borbély, A., van Heerebeek, L., & Paulus, W. J. (2009). Transcriptional and posttranslational modifications of titin: Implications for diastole. Circulation Research, 104(1), 12–14.
Brito, C., & Sousa, S. (2020). Non‐muscle myosin 2A (NM2A): Structure, regulation and function. Cells, 9(7), 1590.
Brown, J. H., & Cohen, C. (2005). Regulation of muscle contraction by tropomyosin and troponin: How structure illuminates function. In Advances in protein chemistry (pp. 121–159). Academic Press.
Brunello, E., Marcucci, L., Irving, M., & Fusi, L. (2023). Activation of skeletal muscle is controlled by a dual‐filament mechano‐sensing mechanism. Proceedings of the National Academy of Sciences of the United States of America, 120(22), e2302837120.
Buss, F., Kendrick‐Jones, J., Lionne, C., Knight, A. E., Côté, G. P., & Paul Luzio, J. (1998). The localization of myosin VI at the golgi complex and leading edge of fibroblasts and its phosphorylation and recruitment into membrane ruffles of A431 cells after growth factor stimulation. The Journal of Cell Biology, 143(6), 1535–1545.
Cao, J., Wu, Q., Huang, Y., Wang, L., Su, Z., & Ye, H. (2021). The role of DNA methylation in syndromic and non‐syndromic congenital heart disease. Clinical Epigenetics, 13(1), 93.
Castellani, L., & Cohen, C. (1987). Myosin rod phosphorylation and the catch state of molluscan muscles. Science, 235(4786), 334–337.
Chapman, E. A., Aballo, T. J., Melby, J. A., Zhou, T., Price, S. J., Rossler, K. J., Lei, I., Tang, P. C., & Ge, Y. (2023). Defining the sarcomeric proteoform landscape in ischemic cardiomyopathy by top‐down proteomics. Journal of Proteome Research, 22(3), 931–941.
Chen, L., Liu, J., Rastegarpouyani, H., Janssen, P. M. L., Pinto, J. R., & Taylor, K. A. (2024). Structure of mavacamten‐free human cardiac thick filaments within the sarcomere by cryoelectron tomography. Proceedings of the National Academy of Sciences of the United States of America, 121(9), e2311883121.
Cieniewski‐Bernard, C., Bastide, B., Lefebvre, T., Lemoine, J., Mounier, Y., & Michalski, J. C. (2004). Identification of O‐linked N‐acetylglucosamine proteins in rat skeletal muscle using two‐dimensional gel electrophoresis and mass spectrometry. Molecular & Cellular Proteomics, 3(6), 577–585.
Cieniewski‐Bernard, C., Montel, V., Berthoin, S., & Bastide, B. (2012). Increasing O‐GlcNAcylation level on organ culture of soleus modulates the calcium activation parameters of muscle fibers. PLoS One, 7(10), e48218.
Cieniewski‐Bernard, C., Montel, V., Stevens, L., & Bastide, B. (2009). O‐GlcNAcylation, an original modulator of contractile activity in striated muscle. Journal of Muscle Research and Cell Motility, 30(7–8), 281–287.
Cooke, R. (1997). Actomyosin interaction in striated muscle. Physiological Reviews, 77(3), 671–697.
Cooke, R. (2004). The sliding filament model: 1972‐2004. The Journal of General Physiology, 123(6), 643–656.
Cope, M. J. T. V., Whisstock, J., Rayment, I., & Kendrick‐Jones, J. (1996). Conservation within the myosin motor domain: Implications for structure and function. Structure, 4(8), 969–987.
de Lanerolle, P. (2012). Nuclear actin and myosins at a glance. Journal of Cell Science, 125(Pt 21), 4945–4949.
de Lanerolle, P., & Serebryannyy, L. (2011). Nuclear actin and myosins: Life without filaments. Nature Cell Biology, 13(11), 1282–1288.
Dillon, P. F., Aksoy, M. O., Driska, S. P., & Murphy, R. A. (1981). Myosin phosphorylation and the cross‐bridge cycle in arterial smooth muscle. Science, 211(4481), 495–497.
Dowling, P., Zweyer, M., Swandulla, D., & Ohlendieck, K. (2019). Characterization of contractile proteins from skeletal muscle using gel‐based top‐down proteomics. Proteomes, 7(2), 25.
Dunphy, K., Dowling, P., Bazou, D., & O'Gorman, P. (2021). Current methods of post‐translational modification analysis and their applications in blood cancers. Cancers (Basel), 13(8), 1930.
Dutta, D., Nguyen, V., Campbell, K. S., Padrón, R., & Craig, R. (2023). Cryo‐EM structure of the human cardiac myosin filament. Nature, 623(7988), 853–862.
Fertig, B., Ling, J., Nollet, E. E., Dobi, S., Busiau, T., Ishikawa, K., Yamada, K., Lee, A., Kho, C., Wills, L., Tibbo, A. J., Scott, M., Grant, K., Campbell, K. S., Birks, E. J., MacQuaide, N., Hajjar, R., Smith, G. L., van der Velden, J., & Baillie, G. S. (2022). SUMOylation does not affect cardiac troponin I stability but alters indirectly the development of force in response to Ca2+. The FEBS Journal, 289(20), 6267–6285.
Figueiredo‐Freitas, C., Dulce, R. A., Foster, M. W., Liang, J., Yamashita, A. M. S., Lima‐Rosa, F. L., Thompson, J. W., Moseley, M. A., Hare, J. M., Nogueira, L., Sorenson, M. M., & Pinto, J. R. (2015). S‐Nitrosylation of sarcomeric proteins depresses myofilament Ca(2+) sensitivity in intact cardiomyocytes. Antioxidants & Redox Signaling, 23(13), 1017–1034.
Fischer, E. H., & Krebs, E. G. (1958). The isolation and crystallization of rabbit skeletal muscle phosphorylase b. The Journal of Biological Chemistry, 231(1), 65–71.
Fossati, A., Frommelt, F., Uliana, F., Martelli, C., Vizovisek, M., Gillet, L., Collins, B., Gstaiger, M., & Aebersold, R. (2021). System‐wide profiling of protein complexes via size exclusion chromatography‐mass spectrometry (SEC‐MS). Methods in Molecular Biology, 2259, 269–294.
Garcia, B. A. (2010). What does the future hold for top down mass spectrometry? Journal of the American Society for Mass Spectrometry, 21(2), 193–202.
Gordon, A. M., Homsher, E., & Regnier, M. (2000). Regulation of contraction in striated muscle. Physiological Reviews, 80(2), 853–924.
Gräter, F., Shen, J., Jiang, H., Gautel, M., & Grubmüller, H. (2005). Mechanically induced titin kinase activation studied by force‐probe molecular dynamics simulations. Biophysical Journal, 88(2), 790–804.
Greenberg, M. J., Mealy, T. R., Watt, J. D., Jones, M., Szczesna‐Cordary, D., & Moore, J. R. (2009). The molecular effects of skeletal muscle myosin regulatory light chain phosphorylation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 297(2), R265–R274.
Gupta, M. K., & Robbins, J. (2014). Post‐translational control of cardiac hemodynamics through myosin binding protein C. Pflügers Archiv, 466(2), 231–236.
Harrington, W. F., & Rodgers, M. E. (1984). Myosin. Annual Review of Biochemistry, 53(1), 35–73.
Herbison, G. J., Jaweed, M. M., & Ditunno, J. F. (1982). Muscle fiber types. Archives of Physical Medicine and Rehabilitation, 63(5), 227–230.
Hermann, J., Schurgers, L., & Jankowski, V. (2022). Identification and characterization of post‐translational modifications: Clinical implications. Molecular Aspects of Medicine, 86, 101066.
Hess, D. T., Matsumoto, A., Kim, S. O., Marshall, H. E., & Stamler, J. S. (2005). Protein S‐nitrosylation: Purview and parameters. Nature Reviews Molecular Cell Biology, 6(2), 150–166.
Hidalgo, C., Hudson, B., Bogomolovas, J., Zhu, Y., Anderson, B., Greaser, M., Labeit, S., & Granzier, H. (2009). PKC phosphorylation of titin's PEVK element: A novel and conserved pathway for modulating myocardial stiffness. Circulation Research, 105(7), 631–638, 17 p following 638.
Hofmann, W. A., Arduini, A., Nicol, S. M., Camacho, C. J., Lessard, J. L., Fuller‐Pace, F. V., & de Lanerolle, P. (2009). SUMOylation of nuclear actin. The Journal of Cell Biology, 186(2), 193–200.
Holroyde, M. J., Potter, J. D., & Solaro, R. J. (1979). The calcium binding properties of phosphorylated and unphosphorylated cardiac and skeletal myosins. The Journal of Biological Chemistry, 254(14), 6478–6482.
Houdusse, A., & Sweeney, H. L. (2001). Myosin motors: Missing structures and hidden springs. Current Opinion in Structural Biology, 11(2), 182–194.
Hu, Z., Taylor, D. W., Reedy, M. K., Edwards, R. J., & Taylor, K. A. (2016). Structure of myosin filaments from relaxed lethocerus flight muscle by cryo‐EM at 6 Å resolution. Science Advances, 2(9), e1600058.
Huxley, H. E. (1985). The crossbridge mechanism of muscular contraction and its implications. The Journal of Experimental Biology, 115, 17–30.
Irving, M., St Claire Alien, T., Sabido‐David, C., Craik, J. S., Brandmeier, B., Kendrick‐Jones, J., Corrie, J. E. T., Trentham, D. R., & Goldman, Y. E. (1995). Tilting of the light‐chain region of myosin during step length changes and active force generation in skeletal muscle. Nature, 375(6533), 688–691.
Jin, Y., Diffee, G. M., Colman, R. J., Anderson, R. M., & Ge, Y. (2019). Top‐down mass spectrometry of sarcomeric protein post‐translational modifications from non‐human primate skeletal muscle. Journal of the American Society for Mass Spectrometry, 30(12), 2460–2469.
Jin, Y., Wei, L., Cai, W., Lin, Z., Wu, Z., Peng, Y., Kohmoto, T., Moss, R. L., & Ge, Y. (2017). Complete characterization of cardiac myosin heavy chain (223 kDa) enabled by size‐exclusion chromatography and middle‐down mass spectrometry. Analytical Chemistry, 89(9), 4922–4930.
Johnson, C. A., Walklate, J., Svicevic, M., Mijailovich, S. M., Vera, C., Karabina, A., Leinwand, L. A., & Geeves, M. A. (2019). The ATPase cycle of human muscle myosin II isoforms: Adaptation of a single mechanochemical cycle for different physiological roles. The Journal of Biological Chemistry, 294(39), 14267–14278.
Kampourakis, T., Sun, Y. B., & Irving, M. (2016). Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments. Proceedings of the National Academy of Sciences of the United States of America, 113(21), E3039–E3047.
Karatsai, O., Lehka, L., Wojton, D., Grabowska, A. I., Duda, M. K., Lenartowski, R., & Redowicz, M. J. (2023). Unconventional myosin VI in the heart: Involvement in cardiac dysfunction progressing with age. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1869(6), 166748.
Kawai, M., Johnston, J. R., Karam, T., Wang, L., Singh, R. K., & Pinto, J. R. (2017). Myosin rod hypophosphorylation and CB kinetics in papillary muscles from a TnC‐A8V KI mouse model. Biophysical Journal, 112(8), 1726–1736.
Khoury, G. A., Baliban, R. C., & Floudas, C. A. (2011). Proteome‐wide post‐translational modification statistics: Frequency analysis and curation of the swiss‐prot database. Scientific Reports, 1, 90.
Kohr, M. J., Aponte, A. M., Sun, J., Wang, G., Murphy, E., Gucek, M., & Steenbergen, C. (2011). Characterization of potential S‐nitrosylation sites in the myocardium. American Journal of Physiology‐Heart and Circulatory Physiology, 300(4), H1327–H1335.
Krebs, E. G., & Fischer, E. H. (1956). The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochimica et Biophysica Acta, 20(1), 150–157.
Krebs, E. G., & Fischer, E. H. (1989). The phosphorylase b to a converting enzyme of rabbit skeletal muscle 1956. Biochimica et Biophysica Acta, 1000, 302–309.
Krendel, M., & Mooseker, M. S. (2005). Myosins: Tails (and heads) of functional diversity. Physiology, 20(4), 239–251.
Krüger, M., & Linke, W. A. (2006). Protein kinase‐A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. Journal of Muscle Research and Cell Motility, 27(5–7), 435–444.
Landim‐Vieira, M., Childers, M. C., Wacker, A. L., Garcia, M. R., He, H., Singh, R., Brundage, E. A., Johnston, J. R., Whitson, B. A., Chase, P. B., Janssen, P. M. L., Regnier, M., Biesiadecki, B. J., Pinto, J. R., & Parvatiyar, M. S. (2022). Post‐translational modification patterns on β‐myosin heavy chain are altered in ischemic and nonischemic human hearts. eLife, 11, e74919.
Lanouette, S., Mongeon, V., Figeys, D., & Couture, J. F. (2014). The functional diversity of protein lysine methylation. Molecular Systems Biology, 10(4), 724.
Lee, A., Oh, J. G., Gorski, P. A., Hajjar, R. J., & Kho, C. (2016). Post‐translational modifications in heart failure: Small changes, big impact. Heart, Lung and Circulation, 25(4), 319–324.
Lefebvre, T., Dehennaut, V., Guinez, C., Olivier, S., Drougat, L., Mir, A. M., Mortuaire, M., Vercoutter‐Edouart, A. S., & Michalski, J. C. (2010). Dysregulation of the nutrient/stress sensor O‐GlcNAcylation is involved in the etiology of cardiovascular disorders, type‐2 diabetes and Alzheimer's disease. Biochimica et Biophysica Acta (BBA) – General Subjects, 1800(2), 67–79.
Lehka, L., Wojton, D., Topolewska, M., Chumak, V., Majewski, Ł., & Rędowicz, M. J. (2022). Loss of unconventional myosin VI affects cAMP/PKA signaling in hindlimb skeletal muscle in an age‐dependent manner. Frontiers in Physiology, 13, 933963.
Levine, R. J., Kensler, R. W., Yang, Z., Stull, J. T., & Sweeney, H. L. (1996). Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. Biophysical Journal, 71(2), 898–907.
Llano‐Diez, M., Renaud, G., Andersson, M., Marrero, H., Cacciani, N., Engquist, H., Corpeño, R., Artemenko, K., Bergquist, J., & Larsson, L. (2012). Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading. Critical Care, 16(5), R209.
Lundby, A., Lage, K., Weinert, B. T., Bekker‐Jensen, D. B., Secher, A., Skovgaard, T., Kelstrup, C. D., Dmytriyev, A., Choudhary, C., Lundby, C., & Olsen, J. V. (2012). Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Reports, 2(2), 419–431.
Malmqvist, U. P., Aronshtam, A., & Lowey, S. (2004). Cardiac myosin isoforms from different species have unique enzymatic and mechanical properties. Biochemistry, 43(47), 15058–15065.
Marston, S., & Pinto, J. R. (2022). Suppression of lusitropy as a disease mechanism in cardiomyopathies. Frontiers in Cardiovascular Medicine, 9, 1080965.
Martin, T. G., & Kirk, J. A. (2020). Under construction: The dynamic assembly, maintenance, and degradation of the cardiac sarcomere. Journal of Molecular and Cellular Cardiology, 148, 89–102.
McNally, E. M., Kraft, R., Bravo‐Zehnder, M., Taylor, D. A., & Leinwand, L. A. (1989). Full‐length rat alpha and beta cardiac myosin heavy chain sequences: Comparisons suggest a molecular basis for functional differences. Journal of Molecular Biology, 210(3), 665–671.
Mermall, V., Post, P. L., & Mooseker, M. S. (1998). Unconventional myosins in cell movement, membrane traffic, and signal transduction. Science, 279(5350), 527–533.
Mnatsakanyan, R., Shema, G., Basik, M., Batist, G., Borchers, C. H., Sickmann, A., & Zahedi, R. P. (2018). Detecting post‐translational modification signatures as potential biomarkers in clinical mass spectrometry. Expert Review of Proteomics, 15(6), 515–535.
Moore, J. R., Leinwand, L., & Warshaw, D. M. (2012). Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor. Circulation Research, 111(3), 375–385.
Muthu, P., Kazmierczak, K., Jones, M., & Szczesna‐Cordary, D. (2012). The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts. Journal of Cellular and Molecular Medicine, 16(4), 911–919.
Nayak, A., Wang, T., Franz, P., Steffen, W., Chizhov, I., Tsiavaliaris, G., & Amrute‐Nayak, M. (2020). Single‐molecule analysis reveals that regulatory light chains fine‐tune skeletal myosin II function. Journal of Biological Chemistry, 295(20), 7046–7059.
Odronitz, F., & Kollmar, M. (2007). Drawing the tree of eukaryotic life based on the analysis of 2,269 manually annotated myosins from 328 species. Genome Biology, 8(9), R196.
Pandeswari, P. B., & Sabareesh, V. (2018). Middle‐down approach: A choice to sequence and characterize proteins/proteomes by mass spectrometry. RSC Advances, 9(1), 313–344.
Persechini, A., Stull, J. T., & Cooke, R. (1985). The effect of myosin phosphorylation on the contractile properties of skinned rabbit skeletal muscle fibers. The Journal of Biological Chemistry, 260(13), 7951–7954.
Pestic‐Dragovich, L., Stojiljkovic, L., Philimonenko, A. A., Nowak, G., Ke, Y., Settlage, R. E., Shabanowitz, J., Hunt, D. F., Hozak, P., & de Lanerolle, P. (2000). A myosin I isoform in the nucleus. Science, 290(5490), 337–341.
Pette, D., & Staron, R. S. (2000). Myosin isoforms, muscle fiber types, and transitions. Microscopy Research and Technique, 50(6), 500–509.
Philimonenko, V. V., Zhao, J., Iben, S., Dingová, H., Kyselá, K., Kahle, M., Zentgraf, H., Hofmann, W. A., de Lanerolle, P., Hozák, P., & Grummt, I. (2004). Nuclear actin and myosin I are required for RNA polymerase I transcription. Nature Cell Biology, 6(12), 1165–1172.
Ramazi, S., & Zahiri, J. (2021). Posttranslational modifications in proteins: Resources, tools and prediction methods. Database: The Journal of Biological Databases and Curation, 2021, baab012.
Ramirez‐Correa, G. A., Jin, W., Wang, Z., Zhong, X., Gao, W. D., Dias, W. B., Vecoli, C., Hart, G. W., & Murphy, A. M. (2008). O‐linked GlcNAc modification of cardiac myofilament proteins: A novel regulator of myocardial contractile function. Circulation Research, 103(12), 1354–1358.
Rayment, I., Holden, H., Whittaker, M., Yohn, C., Lorenz, M., Holmes, K., & Milligan, R. (1993). Structure of the actin‐myosin complex and its implications for muscle contraction. Science, 261(5117), 58–65.
Rayment, I., Rypniewski, W., Schmidt‐Base, K., Smith, R., Tomchick, D., Benning, M., Winkelmann, D., Wesenberg, G., & Holden, H. (1993). Three‐dimensional structure of myosin subfragment‐1: A molecular motor. Science, 261(5117), 50–58.
Ree, R., Varland, S., & Arnesen, T. (2018). Spotlight on protein N‐terminal acetylation. Experimental & Molecular Medicine, 50(7), 1–13.
Russell, B., & Solís, C. (2021). Mechanosignaling pathways alter muscle structure and function by post‐translational modification of existing sarcomeric proteins to optimize energy usage. Journal of Muscle Research and Cell Motility, 42(2), 367–380.
Sandonà, M., Cavioli, G., Renzini, A., Cedola, A., Gigli, G., Coletti, D., McKinsey, T. A., Moresi, V., & Saccone, V. (2023). Histone deacetylases: Molecular mechanisms and therapeutic implications for muscular dystrophies. International Journal of Molecular Sciences, 24(5), 4306.
Sartorius, C. A., Lu, B. D., Acakpo‐Satchivi, L., Jacobsen, R. P., Byrnes, W. C., & Leinwand, L. A. (1998). Myosin heavy chains IIa and IId are functionally distinct in the mouse. The Journal of Cell Biology, 141(4), 943–953.
Schiaffino, S., & Reggiani, C. (1985). Myosin isoforms in mammalian skeletal muscle. Journal of Applied Physiology, 77(2), 493–501.
Schiaffino, S., & Reggiani, C. (1996). Molecular diversity of myofibrillar proteins: Gene regulation and functional significance. Physiological Reviews, 76(2), 371–423.
Schiaffino, S., Rossi, A. C., Smerdu, V., Leinwand, L. A., & Reggiani, C. (2015). Developmental myosins: Expression patterns and functional significance. Skeletal Muscle, 5, 22.
Schoffstall, B., Brunet, N. M., Williams, S., Miller, V. F., Barnes, A. T., Wang, F., Compton, L. A., McFadden, L. A., Taylor, D. W., Seavy, M., Dhanarajan, R., & Chase, P. B. (2006). Ca2+ sensitivity of regulated cardiac thin filament sliding does not depend on myosin isoform. The Journal of Physiology, 577(Pt 3), 935–944.
Siemankowski, R. F., Wiseman, M. O., & White, H. D. (1985). ADP dissociation from actomyosin subfragment 1 is sufficiently slow to limit the unloaded shortening velocity in vertebrate muscle. Proceedings of the National Academy of Sciences of the United States of America, 82(3), 658–662.
Sitbon, Y. H., Yadav, S., Kazmierczak, K., & Szczesna‐Cordary, D. (2020). Insights into myosin regulatory and essential light chains: A focus on their roles in cardiac and skeletal muscle function, development and disease. Journal of Muscle Research and Cell Motility, 41(4), 313–327.
Solaro, R. J. (2008). Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins. The Journal of Biological Chemistry, 283(40), 26829–26833.
Somlyo, A. P., & Somlyo, A. V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372(6503), 231–236.
Sonne, A., Antonovic, A. K., Melhedegaard, E., Akter, F., Andersen, J. L., Jungbluth, H., Witting, N., Vissing, J., Zanoteli, E., Fornili, A., & Ochala, J. (2023). Abnormal myosin post‐translational modifications and ATP turnover time associated with human congenital myopathy‐related RYR1 mutations. Acta Physiologica, 239(2), e14035.
Sonne, A., Peverelli, L., Hernandez‐Lain, A., Domínguez‐González, C., Andersen, J. L., Milone, M., Beggs, A. H., & Ochala, J. (2023). Myosin post‐translational modifications and function in the presence of myopathy‐linked truncating MYH2 mutations. American Journal of Physiology‐Cell Physiology, 324(3), C769–C776.
Spudich, J. A. (2001). The myosin swinging cross‐bridge model. Nature Reviews Molecular Cell Biology, 2(5), 387–392.
Sun, C. F., Li, Y. Q., & Mao, X. M. (2020). Regulation of protein post‐translational modifications on metabolism of actinomycetes. Biomolecules, 10(8), 1122.
Sweeney, H. L., & Holzbaur, E. L. F. (2018). Motor proteins. Cold Spring Harbour Perspectives Biology, 10(5), a021931.
Sweeney, H. L., & Houdusse, A. (2010). Structural and functional insights into the Myosin motor mechanism. Annual Review of Biophysics, 39, 539–557.
Sweeney, H. L., Kushmerick, M. J., Mabuchi, K., Gergely, J., & Sreter, F. A. (1986). Velocity of shortening and myosin isozymes in two types of rabbit fast‐twitch muscle fibers. The American Journal of Physiology, 251(3 Pt 1), C431–C434.
Sweeney, H. L., & Stull, J. T. (1990). Alteration of cross‐bridge kinetics by myosin light chain phosphorylation in rabbit skeletal muscle: Implications for regulation of actin‐myosin interaction. Proceedings of the National Academy of Sciences of the United States of America, 87(1), 414–418.
Sweeney, H. L., Yang, Z., Zhi, G., Stull, J. T., & Trybus, K. M. (1994). Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation. Proceedings of the National Academy of Sciences of the United States of America, 91(4), 1490–1494.
Tamborrini, D., Wang, Z., Wagner, T., Tacke, S., Stabrin, M., Grange, M., Kho, A. L., Rees, M., Bennett, P., Gautel, M., & Raunser, S. (2023). Structure of the native myosin filament in the relaxed cardiac sarcomere. Nature, 623(7988), 863–871.
Tilemann, L., Lee, A., Ishikawa, K., Aguero, J., Rapti, K., Santos‐Gallego, C., Kohlbrenner, E., Fish, K. M., Kho, C., & Hajjar, R. J. (2013). SUMO‐1 gene transfer improves cardiac function in a large‐animal model of heart failure. Science Translational Medicine, 5(211), 211ra159.
Van Driest, S. L., Ackerman, M. J., Ommen, S. R., Shakur, R., Will, M. L., Nishimura, R. A., Tajik, A. J., & Gersh, B. J. (2002). Prevalence and severity of "benign" mutations in the beta‐myosin heavy chain, cardiac troponin T, and alpha‐tropomyosin genes in hypertrophic cardiomyopathy. Circulation, 106(24), 3085–3090.
van Rooij, E., & Olson, E. N. (2007). MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. The Journal of Clinical Investigation, 117(9), 2369–2376.
Vicente‐Manzanares, M., Ma, X., Adelstein, R. S., & Horwitz, A. R. (2009). Non‐muscle myosin II takes centre stage in cell adhesion and migration. Nature Reviews. Molecular Cell Biology, 10(11), 778–790.
Wang, H., Yang, L., Liu, M., & Luo, J. (2023). Protein post‐translational modifications in the regulation of cancer hallmarks. Cancer Gene Therapy, 30(4), 529–547.
Wang, J., & Schwartz, R. J. (2010). Sumoylation and regulation of cardiac gene expression. Circulation Research, 107(1), 19–29.
Wang, L., Geist, J., Grogan, A., Hu, L. R., & Kontrogianni‐Konstantopoulos, A. (2018). Thick filament protein network, functions, and disease association. Comprehensive Physiology, 8(2), 631–709.
Wiseman, R., Brown, C. M., Beck, T. W., Brault, J. J., Reinoso, T. R., Shi, Y., & Chase, P. B. (2023). Creatine kinase equilibration and ΔGATP over an extended range of physiological conditions: Implications for cellular energetics, signaling and muscle performance. International Journal of Molecular Sciences, 24(17), 13244.
Yan, K., Wang, K., & Li, P. (2019). The role of post‐translational modifications in cardiac hypertrophy. Journal of Cellular and Molecular Medicine, 23(6), 3795–3807.
Yang, Q., Hewett, T. E., Klevitsky, R., Sanbe, A., Wang, X., & Robbins, J. (2001). PKA‐dependent phosphorylation of cardiac myosin binding protein C in transgenic mice. Cardiovascular Research, 51(1), 80–88.
Zhang, R., Zhao, J., Mandveno, A., & Potter, J. D. (1995). Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circulation Research, 76(6), 1028–1035.